Horvath R, Lochmüller H, Stucka R, Yao J, Shoubridge E A, Kim S H, Gerbitz K D, Jaksch M
Metabolic Disease Centre Munich, Institute of Clinical Chemistry, Munich, Germany.
Biochem Biophys Res Commun. 2000 Sep 24;276(2):530-3. doi: 10.1006/bbrc.2000.3495.
At least three proteins, COX17p, SCO1p, and its homologue SCO2p are thought to be involved in mitochondrial copper transport to cytochrome-c-oxidase (COX), the terminal enzyme of the respiratory chain. Recently, we and others have shown that mutations in SCO2 are associated with a lethal infantile hypertrophic cardiomyopathy (HCMP) with COX-deficiency. The majority of patients with a similar phenotype were, however, negative for SCO2 mutations, suggesting the other genes as candidates for this disorder. Here we report on the genomic organization of SCO1 and COX17 on human chromosomes 17 and 3 respectively, and the complete sequence analysis of COX17 and SCO1 in 30 patients with COX deficiency. Using a panel of human:mouse-monochromosomal hybrids, the expression of COX17 was specifically restricted to chromosome 3, indicating that the previously reported sequence on chromosome 13 represents a pseudogene. DNA sequence analysis of SCO1 and COX17 in nine patients with severe COX deficiency and fatal HCMP, and in 21 patients with other COX deficiency disorders, did not reveal any pathogenic mutations or polymorphisms. We conclude that neither SCO1 nor COX17 are common causes of COX deficiency disorders.
至少有三种蛋白质,即COX17p、SCO1p及其同源物SCO2p,被认为参与了线粒体铜向细胞色素c氧化酶(COX)的转运,COX是呼吸链的末端酶。最近,我们和其他人已经表明,SCO2中的突变与一种伴有COX缺乏的致命性婴儿肥厚性心肌病(HCMP)有关。然而,大多数具有相似表型的患者SCO2突变呈阴性,这表明其他基因可能是这种疾病的候选基因。在这里,我们分别报告了SCO1和COX17在人类17号和3号染色体上的基因组结构,以及对30例COX缺乏患者的COX17和SCO1的完整序列分析。使用一组人鼠单染色体杂种,COX17的表达特异性地局限于3号染色体,这表明先前在13号染色体上报道的序列代表一个假基因。对9例严重COX缺乏和致命性HCMP患者以及21例其他COX缺乏症患者的SCO1和COX17进行DNA序列分析,未发现任何致病突变或多态性。我们得出结论,SCO1和COX17都不是COX缺乏症的常见病因。